GENEDRIVE
Last Updated: 15/12/2025 10:10 AM
SHARE PRICE
0.95
CHANGE
-0.05 ( -5%) >
TICKER
GDR.L
Share Chart
Latest Articles for GDR.L
Genedrive narrows loss as revenue nearly doubles on MT-RNR1 test
December 5th, 2025
(Alliance News) - Genedrive PLC on Friday reported a narrowed full-year loss as its net finance costs fell and revenue almost doubled from routine use of its MT-RNR1 test....
IN BRIEF: Genedrive says new data shows "positive case" for CYP2C19
December 1st, 2025
Genedrive PLC - Manchester, England-based point-of-care pharmacogenetic testing company - Notes the presentation of two posters by authors from the NHS England Network of Excellence in Pharmacogenomics, the NHSE Genomics...
IN BRIEF: Genedrive kicks off MT-RNR1 ID Scottish hospital roll out
November 26th, 2025
Genedrive PLC - Manchester-based point-of-care pharmacogenetic testing company - says its MT-RNR1 ID kit will start being used for babies requiring antibiotic treatment for infections at the Royal Hospital for...
IN BRIEF: Genedrive hails memorandum with Saudi Ministry of Health
October 28th, 2025
Genedrive PLC - Manchester-based point-of-care pharmacogenetic testing company - Announces that its exclusive distribution partner in Saudi Arabia, iDeal iDea for Medical Equipment Technology, has signed a memorandum of understanding...